Education
About Us
Working with TipRanks
Follow Us
Liquidia Technologies Inc (LQDA)
NASDAQ:LQDA
Earnings Data
Report Date
Aug 07, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.43Last Year’s EPS
-0.37Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 08, 2025
|% Change Since: -1.74%
|Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive strategic developments and legal victories, particularly regarding the potential launch of YUTREPIA and favorable court rulings. However, this was balanced by financial challenges such as increased operational costs and a larger net loss compared to the previous year.Company Guidance
During the Liquidia Corporation First Quarter 2025 Financial Results and Corporate Update Conference Call, detailed guidance was provided on several key strategic areas in preparation for the potential launch of YUTREPIA, an investigational inhaled dry powder formulation of treprostinil. The company is focusing on developing a best-in-class product profile, emphasizing YUTREPIA's tolerability, titratability, and ease of use. Cohort A of the ASCENT study is fully enrolled with over 50 patients, showing promising interim results, including the ability of PH-ILD patients to titrate to doses 3 times higher than the labeled target dose of nebulized Tyvaso, with positive trends in 6-minute walk distance. The commercial team is ready with 50 sales reps and a companion medical affairs team, all with significant rare disease experience. Additionally, they have prepared a full suite of patient support services and ensured that product availability can commence within 2 to 3 weeks post-approval. The company has also cultivated strong relationships with payers to ensure broad access for patients. Financially, Liquidia reported a revenue of $3.1 million for the quarter ended March 31, 2025, with research and development expenses decreasing by 31% compared to the previous year, attributed to a shift towards commercialization activities. The net loss for the quarter was $38.4 million, or $0.45 per share, compared to a net loss of $30.1 million, or $0.40 per share, in the same period of 2024.Court Decision Favoring Liquidia
The District Court dismissed United Therapeutics’ cross-claim against Liquidia, clearing legal barriers for YUTREPIA’s potential approval.
ASCENT Study Progress
Cohort A of the ASCENT study is fully enrolled with over 50 patients, showing promising interim data with positive trends in efficacy measures such as 6-minute walk distance.
Strategic Preparations for YUTREPIA Launch
Liquidia is preparing for the launch of YUTREPIA with a focus on product profile, sales force readiness, patient support services, product availability, and payer access.
Reduction in R&D Expenses
Research and development expenses decreased by $3.1 million (31%) compared to the previous year, reflecting a shift towards commercialization.
---
LQDA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
LQDA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2025 | $15.53 | $15.35 | -1.16% |
Mar 19, 2025 | $14.74 | $14.92 | +1.22% |
Nov 13, 2024 | $10.63 | $10.27 | -3.39% |
Aug 07, 2024 | $11.06 | $10.68 | -3.44% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Liquidia Technologies Inc (LQDA) report earnings?
Liquidia Technologies Inc (LQDA) is schdueled to report earning on Aug 07, 2025, TBA Not Confirmed.
What is Liquidia Technologies Inc (LQDA) earnings time?
Liquidia Technologies Inc (LQDA) earnings time is at Aug 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LQDA EPS forecast?
LQDA EPS forecast for the fiscal quarter 2025 (Q2) is -0.43.
---